Adjuvant Chemotherapy in Breast Cancer after Neoadjuvant Therapy: Essential or Optional?
This study efficiently differentiates between varying levels of risk, enabling clinicians to identify patients unlikely to benefit from postoperative AC and thus reduce the likelihood of overtreatment.
Authors
- Yang Luo (ORCID: https://orcid.org/0000-0002-0166-9027)
- Qi Zhou (ORCID: https://orcid.org/0000-0001-5673-4263)
- Yuan Zheng (ORCID: https://orcid.org/0000-0002-4991-0190)
- Di Zhang (ORCID: https://orcid.org/0009-0000-5802-4150)
Institutions
- Shandong Provincial QianFoShan Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-04-24
- DOI
- https://doi.org/10.4143/crt.2024.1254
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00